Professor
Michael A. Santoro,
J.D., Ph.D.

Teaching

Michael A. Santoro is Professor of Management and Entrepreneurship at the Leavey School of Business at Santa Clara University. Previously he was a Professor at Rutgers Business School for two decades. As a Research Associate at Harvard Business School, Prof. Santoro authored numerous case studies and teaching notes. He practices the Harvard “case method” of teaching which emphasizes guided discussion, decision-making, and experiential learning for students. He has given a number of “train the trainers” seminars on the art and science of case method teaching for both business and law faculty.

Prof. Santoro was voted “Professor of the Year” by Rutgers MBA students in 2013. He was a Fellow of the RBS Teaching Excellence Center and has also served as a GE Teaching Fellow.

Prof. Santoro has been a visiting faculty member at the University of Notre Dame, the Shanghai Advanced Institute of Finance at Shanghai Jiao Tong University, the Sinopec Management Institute in Beijing, and the University of Zurich, as well as an Adjunct Lecturer and Teaching Fellow at Harvard’s John F. Kennedy School of Government where he taught ethics and economics courses.

Speaking

Prof. Santoro is a frequent featured speaker on business ethics, pharmaceutical industry ethics, human rights, and financial industry ethics at numerous venues, including:

Business Ethics Videos

Below you will find an introduction to business ethics. The whole cycle of videos takes approximately 24 minutes to complete.

Books

A China Business Primer:Ethics, Culture, and Relationships

Routledge, 2021

Wall Street Values:Business Ethics and the Global Financial Crisis

Cambridge UP, 2013

Ethics and the Pharmaceutical Industry

Cambridge UP, 2005

China 2020:How Western Business Can — and Should — Influence Social and Political Change in the Coming Decade

Cornell UP, 2009

Profits and Principles:Global Capitalism and Human Rights in China

Cornell UP, 2000

Other Writing

Op-Eds and Blogs

• “Lessons of COVID-19 Vaccines for Progressive Utopians”, Business & Human Rights Resource Centre, February 10, 2021
• “The Avocado Toast on the Wall: The Paradox of China’s Rise”, Pacific Council on International Policy, May 15, 2018 (With Robert Shanklin)
• “‘Trickle in’ economics: How Dems should talk about infrastructure investment”, The Hill, January 5, 2018
• “Outside-In and Inside-Out Human Rights Measurement Tools”, LSE Forum Series, September 2015
• “Can A Disgraced Trader Get A Job in Academia?”, The New Yorker, January 22, 2014
• “Why the JPMorgan Settlement Falls Short”, The New Yorker, September 18, 2013
• “Would Better Regulations Have Prevented the London Whale Trades?”, The New Yorker, August 21, 2013
• “Big Fish, Little Fish, and the S.E.C.”, The New Yorker, August 2, 2013
• “Why Haven’t the S.E.C.’s Lawyers Held Wall Street Accountable?”, The New Yorker, July 31, 2013
• “Should LDCs Love MNCs?”, Foreign Policy, January/February 2002
• “The Pressure on China Needs Flexibility and Focus”, International Herald Tribune, March 11, 1994

Articles

• “Human rights obligations of drug companies,” Journal of Human Rights, Vol. 19, No. 5, 2020 (With Robert Shanklin)
• “Business and Human Rights in Historical Perspective,” Journal of Human Rights, Vol. 14, No. 2, 2015
• “The Ethics and Economics of Pharmaceutical Pricing,” Annual Review of Pharmacology and Toxicology, Vol. 55, 2015
  (With Sara Parker-Lue and Greg Koski)
• “Too big and too interconnected to fail,” International Journal of Sustainable Economy, Vol. 4, No. 4, 2012 (With Ronald J. Strauss)
• “Post-Westphalia and its Discontents,” Business Ethics Quarterly, Vol. 20, No. 2, 2010
• “Pharmaceutical Policy in China,” Health Affairs, Vol. 27, No. 4, 2008 (With Qiang Sun et al.)
• “Beyond Codes of Conduct and Monitoring,” Human Rights Quarterly, Vol. 25, No. 2, 2003
• “Global Capitalism and the Road to Chinese Democracy,” Current History, Vol. 99, No. 638, 2000
• “Engagement with Integrity,” Business & the Contemporary World, Vol. X, No. 1, 1998
• “The WTO and Workers’ Rights,” Harvard Journal of World Affairs, Vol. III, No. 1, 1995

Consulting & Expert Witness Work

Prof. Santoro firmly believes that the link between good ethics and good business is ever tightening in the modern business environment. Companies have two mechanisms for successfully managing ethics that are akin to the way your computer works. There’s the hardware — the policies and processes that a company institutionalizes. Then there’s the software — the company culture, the leadership and “tone at the top.”

There’s a huge competitive edge to be gained when your hardware is properly aligned to the right ethical standards. Not only does well designed hardware protect the company, but the right hardware also guides people to make choices that are both principled and profitable.

In the Press

MAS Business Ethics & Human Rights Lab

Cultivating a community that centers ethics and human rights at the heart of Jesuit business education and research.

As the economy grows to be increasingly globalized, businesses all over the world face more human rights challenges. From supply chain to PR, every aspect of a business and decision made interacts with business ethics.

Researchers in the Michael A. Santoro Business Ethics and Human Rights Lab (MAS BEHR), along with professionals across the globe, explore these interactions to identify business models that address human rights. The lab is research based and composed of skilled undergraduates chosen by Professor of Management and Entrepreneurship Michael Santoro.

The MAS BEHR is one of the first undergraduate research labs of its kind. Through working closely with Professor Santoro’s recent research, fellows think critically about current human rights challenges across multiple industries.

Contact